Results 171 to 180 of about 44,049 (225)

STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasms. [PDF]

Am J Cancer Res
Rozic G, Makaros Y, Shapira-Netanelov I, Kardash T, Maizels Y, Koman I, Leiba M, Duek A.   +7 more
europepmc   +1 more source

The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted Therapeutics. [PDF]

Cancers (Basel)
Bonuomo V, Dogliotti I, Masucci S, Grano S, Savi A, Frolli A, Cilloni D, Fava C.   +7 more
europepmc   +1 more source

Interleukin-2 and Tretinoin for Myeloproliferative Neoplasms and to Target Type 1 Calreticulin-Driven Neoplasms: Advancements in Immune Regenerative Medicine. [PDF]

Int J Mol Sci
Maharaj D, Zhang W, Kaur K, Gouvea J.
europepmc   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study. [PDF]

EJHaem
Vojjala N, Shah R, Gibatova V, Kattamuri L, Agrawal S, Krishnamoorthy G, Patell R.   +6 more
europepmc   +1 more source

Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis. [PDF]

EJHaem
Blanco-Sánchez A, Ayala R, Carreño-Tarragona G, Colmenares R, López-Muñoz N, Sáez A, Palacios-Berraquero ML, Hernández J, Martínez-López J, Martínez-López J.   +9 more
europepmc   +1 more source

Gender influences prognosis of classical BCR::ABL1 negative myeloproliferative neoplasms: a retrospective cohort study. [PDF]

Discov Oncol
Cai Y, Wang Y, Zhang P, Zhu Z.
europepmc   +1 more source

Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasms. [PDF]

Transl Oncol
De Moner B, Martinez-Sanchez J, Escribano-Serrat S, Ramos A, Moreno-Castaño AB, Arellano-Rodrigo E, Escolar G, Carreras E, Álvarez-Larrán A, Diaz-Ricart M.   +9 more
europepmc   +1 more source

NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms. [PDF]

Nat Commun
Koerber RM, Krollmann C, Cieslak K, Tregel E, Saenz ML, Brümmendorf TH, Koschmieder S, Griesshammer M, Gütgemann I, Baldauf CK, Fischer T, Brossart P, Kolbe CC, Latz E, Wolf D, Teichmann LL.   +15 more
europepmc   +1 more source

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms. [PDF]

Blood Cancer J
Meyer R, Rodriguez MJ, Caduc M, Kricheldorf K, Begemann M, Kraft F, Spier I, Dey D, Güzel N, Becker K, Baumeister J, S de Toledo MA, Isfort S, Germing U, Aretz S, Brümmendorf TH, Kurth I, Elbracht M, Teichmann LL, Koschmieder S.   +19 more
europepmc   +1 more source

Targeting mitochondrial dysfunction in myeloproliferative neoplasms: current strategies and future directions - a narrative review. [PDF]

Ann Med Surg (Lond)
Dirani NA, Soufan F, Jebawi KA, Satea Shafeea M, Nasereldeen N, Sabra I, Mhanna Z, Sajjad W, Khalil A, Chaurasia B, Nasrallah J.   +10 more
europepmc   +1 more source